LeonaBio (LONA) EBT (2019 - 2026)
LeonaBio (LONA) posted quarterly EBT of -$21.1 million for Q1 2026, down 96.12% year-over-year from -$543.5 million in Q1 2025, and up 73.81% quarter-over-quarter from -$80.6 million in Q4 2025.
LeonaBio (LONA) EBT (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported EBT for 8 consecutive years, with -$21.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 96.12% year-over-year to -$21.1 million; the TTM figure through Mar 2026 stood at -$118.0 million (up 33.75% YoY), while the FY2025 annual figure was -$105.6 million, down 8.98% from the prior year.
- EBT advanced to -$21.1 million in Q1 2026 per LONA's latest filing, from -$80.6 million in the prior quarter.
- Across five years, EBT topped out at -$7.9 million in Q3 2025 and bottomed at -$107.5 million in Q4 2024.
- Historically, EBT has averaged -$33.8 million across 5 years, with a median of -$29.4 million in 2023.
- Annual changes were most pronounced in 2024 — EBT plunged 265.68% — and 2025, when it surged 74.74%.
- LeonaBio's EBT stood at -$33.3 million in 2022, then grew by 11.77% to -$29.4 million in 2023, then slumped by 265.68% to -$107.5 million in 2024, then climbed by 25.04% to -$80.6 million in 2025, then jumped by 73.81% to -$21.1 million in 2026.
- Business Quant data shows LONA's EBT at -$21.1 million in Q1 2026, -$80.6 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | LeonaBio | 182.69 Mn | 131.62 Mn | - | -19.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.11 Mn |
| Dec 31, 2025 | -80.60 Mn |
| Sep 30, 2025 | -7.86 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Mar 31, 2025 | -10.76 Mn |
| Dec 31, 2024 | -107.52 Mn |
| Sep 30, 2024 | -31.09 Mn |
| Jun 30, 2024 | -28.68 Mn |
| Mar 31, 2024 | -29.40 Mn |
| Dec 31, 2023 | -29.40 Mn |
| Sep 30, 2023 | -36.99 Mn |
| Jun 30, 2023 | -33.71 Mn |
| Mar 31, 2023 | -31.95 Mn |
| Dec 31, 2022 | -33.32 Mn |
| Sep 30, 2022 | -26.54 Mn |
| Jun 30, 2022 | -24.36 Mn |
| Mar 31, 2022 | -33.52 Mn |
| Dec 31, 2021 | -18.78 Mn |
| Sep 30, 2021 | -23.83 Mn |
| Jun 30, 2021 | -24.34 Mn |